Article

Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Author(s):

Ben Leach

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Related Videos
Skin of Color Savvy: News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities
Medical Sisterhood: James Del Rosso, DO
5 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Related Content
Eric Simpson, MD, Frances J. Storrs, M.D. Medical Dermatology Professor, Dermatology, School of Medicine, Oregon Health & Science University
February 19th 2025

Ruxolitinib Shows Clinical Benefit in Children, Adults With Atopic Dermatitis

Victoria Johnson
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
February 15th 2025

Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Jonathan Bernstein, MD, FAAAAI I Credit: Bernstein Allergy Group
February 18th 2025

Unmet Need for Advanced Chronic Spontaneous Urticaria Treatments Highlighted in Study

Chelsie Derman
Kidney Compass: Navigating Clinical Trials
February 13th 2025

Kidney Compass: Applying Hierarchical Composite Endpoints in Kidney Disease Trials

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
FDA Grants RMAT Designation to RPESC-RPE-4W Transplantation for Dry AMD | Image Credit: US Food and Drug Administration
February 18th 2025

FDA Grants RMAT Designation to RPESC-RPE-4W Transplantation for Dry AMD

Connor Iapoce
Liver | Credit: Adobe Stock
February 18th 2025

Namodenoson Improves Decompensated Liver Cirrhosis Episodes

Abigail Brooks, MA
© 2025 MJH Life Sciences

All rights reserved.